Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-11-12
|
pubmed:abstractText |
Zidovudine can induce a mitochondrial myopathy with ragged-red fibers and partial cytochrome c oxidase deficiency. In an attempt to improve histological assessment of zidovudine myopathy, we evaluated cytochrome c oxidase histochemical reaction in the muscle of 10 patients with biopsy-proven zidovudine myopathy (Group 1), 10 myopathic zidovudine receivers without typical histopathological features of zidovudine myopathy (Group 2), and 10 human immunodeficiency virus (HIV)-infected patients not treated by zidovudine who had an immunohistological profile of HIV-associated myopathy or other neuromuscular disorders (Group 3). Among zidovudine receivers, cytochrome c oxidase deficiency was found in 10 of 10 patients from Group 1 and 7 of 10 from Group 2. No cytochrome c oxidase deficiency was observed in patients not treated by zidovudine. When present, cytochrome c oxidase-negative fibers accounted for 2 to 28% of fibers, and there was no difference for the number of cytochrome c oxidase-negative fibers between Group 1 and Group 2. Most patients with cytochrome c oxidase deficiency that could be evaluated clinically after muscle biopsy improved after withdrawal of zidovudine (5 of 7 in Group 1, 5 of 5 in Group 2). Patients who did not improve had an HIV-associated myopathy concurrently with zidovudine myopathy. We conclude that cytochrome c oxidase reaction may be used as a reliable marker of zidovudine mitochondrial toxicity in HIV-infected patients with muscular symptoms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0364-5134
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
561-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8215243-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:8215243-Adult,
pubmed-meshheading:8215243-Aged,
pubmed-meshheading:8215243-Cytochrome-c Oxidase Deficiency,
pubmed-meshheading:8215243-Female,
pubmed-meshheading:8215243-Humans,
pubmed-meshheading:8215243-Male,
pubmed-meshheading:8215243-Middle Aged,
pubmed-meshheading:8215243-Mitochondrial Myopathies,
pubmed-meshheading:8215243-Zidovudine
|
pubmed:year |
1993
|
pubmed:articleTitle |
Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
|
pubmed:affiliation |
Department of Pathology (Neuropathology), Hospital Henri Mondor, Créteil, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|